PRESS RELEASE
21 November 2025

Proskauer Advises Consortium Of Investors On Investment Into EXALTA Group

PR
Proskauer Rose LLP

Contributor

The world’s leading organizations and global players choose Proskauer to represent them when they need it the most. Our top tier team of star trial attorneys, acclaimed transactional lawyers and exceptionally talented partners and associates have earned a reputation for the relentless pursuit of perfection and a dauntless pursuit of success.
LONDON, November 18, 2025 &ndash Proskauer advised a consortium of investors on their investment through a hybrid preferred share structure into EXALTA Group...
United States

LONDON, November 18, 2025 &ndash Proskauer advised a consortium of investors on their investment through a hybrid preferred share structure into EXALTA Group, formed via the strategic merger of three Montagu owned business (previously Tyber Medical, Intech and Resolve Surgical Technologies).

The investor consortium was led by Marathon Asset Management, and included Kinnerton Hill and Littlejohn & Co., LLC.

With operations across multiple continents, EXALTA Group is a global solutions provider for the MedTech industry. Through its Manufacturing Solutions and Integrated OEM Solutions business units, the company supports leading OEMs in delivering breakthrough medical devices that improve patient outcomes worldwide.

The Proskauer team was led by partnersFaisal Ramzan(Private Credit) andAdam Creed(Private Equity M&A). The team also included associateCharles Jemmett(Private Equity M&A) and associatesEmin Moskofian,Aaron WongandJodie MacNamee(Private Credit).

Contributor

The world’s leading organizations and global players choose Proskauer to represent them when they need it the most. Our top tier team of star trial attorneys, acclaimed transactional lawyers and exceptionally talented partners and associates have earned a reputation for the relentless pursuit of perfection and a dauntless pursuit of success.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More